NO20063603L - Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel - Google Patents

Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel

Info

Publication number
NO20063603L
NO20063603L NO20063603A NO20063603A NO20063603L NO 20063603 L NO20063603 L NO 20063603L NO 20063603 A NO20063603 A NO 20063603A NO 20063603 A NO20063603 A NO 20063603A NO 20063603 L NO20063603 L NO 20063603L
Authority
NO
Norway
Prior art keywords
testicle
procedure
vaccination against
bvdv infection
against bvdv
Prior art date
Application number
NO20063603A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Aaron Ellsworth
Cassius Mcallister Tucker
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20063603L publication Critical patent/NO20063603L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20063603A 2004-03-17 2006-08-09 Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel NO20063603L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55386704P 2004-03-17 2004-03-17
PCT/IB2005/000610 WO2005089793A1 (en) 2004-03-17 2005-03-04 Method of vaccination against testicular bvdv infection

Publications (1)

Publication Number Publication Date
NO20063603L true NO20063603L (no) 2006-09-08

Family

ID=34961163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063603A NO20063603L (no) 2004-03-17 2006-08-09 Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel

Country Status (23)

Country Link
US (1) US20080260778A1 (zh)
EP (1) EP1727562B1 (zh)
JP (1) JP4105220B2 (zh)
KR (2) KR20060127199A (zh)
CN (1) CN1929859A (zh)
AR (1) AR048671A1 (zh)
AT (1) ATE398462T1 (zh)
AU (1) AU2005224179B2 (zh)
BR (1) BRPI0508941A (zh)
CA (1) CA2560532A1 (zh)
DE (1) DE602005007584D1 (zh)
DK (1) DK1727562T3 (zh)
ES (1) ES2306101T3 (zh)
NO (1) NO20063603L (zh)
NZ (1) NZ549592A (zh)
PL (1) PL1727562T3 (zh)
PT (1) PT1727562E (zh)
RU (1) RU2335298C2 (zh)
SI (1) SI1727562T1 (zh)
TW (1) TWI306404B (zh)
UA (1) UA86405C2 (zh)
WO (1) WO2005089793A1 (zh)
ZA (1) ZA200607132B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
CN103338785B (zh) * 2010-09-21 2015-01-14 英特维特国际股份有限公司 Bvdv疫苗
KR101554080B1 (ko) * 2010-12-27 2015-09-17 일라이 릴리 앤드 캄파니 1b형 소 바이러스성 설사 바이러스 백신 조성물 및 방법
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) * 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) * 2001-06-19 2003-08-12 Pentax Corporation Focused image tremble correcting device
WO2003020204A2 (en) * 2001-08-09 2003-03-13 Syracuse Bioanalytical, Inc. Detection of bovine viral diarrhea virus in tissue samples

Also Published As

Publication number Publication date
TWI306404B (en) 2009-02-21
EP1727562A1 (en) 2006-12-06
JP2007529498A (ja) 2007-10-25
DE602005007584D1 (de) 2008-07-31
CA2560532A1 (en) 2005-09-29
ATE398462T1 (de) 2008-07-15
ZA200607132B (en) 2008-08-27
BRPI0508941A (pt) 2007-08-14
WO2005089793A1 (en) 2005-09-29
PT1727562E (pt) 2008-09-05
AU2005224179A1 (en) 2005-09-29
US20080260778A1 (en) 2008-10-23
PL1727562T3 (pl) 2008-10-31
UA86405C2 (ru) 2009-04-27
CN1929859A (zh) 2007-03-14
DK1727562T3 (da) 2008-09-15
AU2005224179B2 (en) 2007-08-23
KR20080036160A (ko) 2008-04-24
TW200531701A (en) 2005-10-01
RU2006133328A (ru) 2008-03-27
JP4105220B2 (ja) 2008-06-25
ES2306101T3 (es) 2008-11-01
KR20060127199A (ko) 2006-12-11
SI1727562T1 (sl) 2008-10-31
AR048671A1 (es) 2006-05-17
NZ549592A (en) 2008-12-24
EP1727562B1 (en) 2008-06-18
RU2335298C2 (ru) 2008-10-10

Similar Documents

Publication Publication Date Title
EA200901241A1 (ru) Соединения для лечения гепатита с
NO20070751L (no) Inhibitorer av HCV-replifikasjon
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
NO20091845L (no) Macrocykliske peptider som hepatitt C virus-inhibitorer
NO20091846L (no) Makrocykliske peptider som hepatitt C virus- inhibitorer
NO20090453L (no) Hepatitt C Virusinhibitorer
EA201270275A1 (ru) Кристаллическое соединение пиридазина
NO20063603L (no) Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel
NO20091591L (no) Hepatitt C virusinhibitorer
TNSN07252A1 (en) Indole derivatives for treating viral infections
NO20072235L (no) HCV-hemmende bicykliske pyrimidiner
EA201200890A1 (ru) Комбинированная терапия hcv
NO20062146L (no) Nukleosidforbindelser for behandling av virusinfeksjoner
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
DK1951296T3 (da) Celleafledte virale vacciner med lave niveauer af restcelle-DNA
DK1569929T3 (da) Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
EA200900298A1 (ru) Ингибиторы вируса гепатита с
MX2012000959A (es) Inhibidores de los virus flaviviridae.
WO2008021936A3 (en) Hepatitis c virus inhibitors
EA201001275A1 (ru) Конформационно-ограниченные бифенильные производные для применения в качестве ингибиторов вируса гепатита с
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
NO20092053L (no) HCV NS3-proteaseinhibitorer
EA201390538A1 (ru) Противовирусные соединения
NO20091706L (no) Inhibitorer av hepatitt C virus
MX2010008749A (es) Inhibidores del virus de la hepatitis c.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application